Approvals/TGA/Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial

Approved

STANDARD

Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3c667f7a0f928d78
Product Name: Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial
Artg Id: 183622
Artg Name: Levophed 1:1000 noradrenaline (norepinephrine) 4mg / 4mL Concentrate for IV Injection vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2012-11-29
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9f80bdccd58fa4235da44fb3aaccb57a.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1ac696d9b3549fc2bf1028bf7298da3e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3c667f7a0f928d78

Type

Standard